Evidence map›Paper›PMID 37115796›Full record

ArticlePloS one2023

Sex-specific effects of CD248 on metabolism and the adipose tissue lipidome.

Kieran Patrick, Xiang Tian, David Cartwright, Silke Heising, Matthew S Glover, Ellie N Northall, Lisa Cazares, Sonja Hess, David Baker, Christopher Church and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Kieran PatrickInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0002-4587-6220
Xiang TianDynamic Omics, Centre for Genomics Research, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States of America.
David CartwrightInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Silke HeisingInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Matthew S GloverDynamic Omics, Centre for Genomics Research, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States of America.
Ellie N NorthallInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0003-4694-2071
Lisa CazaresDynamic Omics, Centre for Genomics Research, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States of America.
Sonja HessDynamic Omics, Centre for Genomics Research, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States of America.
David BakerBioPharmaceuticals R&D, Cardiovascular, Renal and Metabolism (CVRM), Cambridge, United Kingdom.
Christopher ChurchBioPharmaceuticals R&D, Cardiovascular, Renal and Metabolism (CVRM), Cambridge, United Kingdom.
Graeme DaviesBioPharmaceuticals R&D, Cardiovascular, Renal and Metabolism (CVRM), Cambridge, United Kingdom.
Gareth LaveryInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom.
Amy J NaylorInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0001-8384-8215
University of Birmingham · GBAstraZeneca (United States) · US

Funding

Versus Arthritis 21743
6 · The paper itself

Abstract

Cd248 has recently been associated with adipose tissue physiology, demonstrated by reduced weight gain in high fat diet-fed mice with genetic deletion of Cd248 relative to controls. Here we set out to determine the metabolic consequences of loss of Cd248. Strikingly, we find these to be sex specific; By subjecting Cd248-/- and Cd248+/+ mice to a high fat diet and indirect calorimetry study, we identified that only male Cd248-/- mice show reduced weight gain compared to littermate control wildtype mice. In addition, male (but not female) mice showed a lower respiratory exchange ratio on both chow and high fat diets, indicating a predisposition to metabolise lipid. Lipidomic studies on specific fat depots found reduced triglyceride and diglyceride deposition in male Cd248-/- mice, and this was supported by reduced expression of lipogenic and adipogenic genes. Finally, metabolomic analysis of isolated, differentiated preadipocytes found alterations in metabolic pathways associated with lipid deposition in cells isolated from male, but not female, Cd248-/- mice. Overall, our results highlight the importance of sex controls in animal studies and point to a role for Cd248 in sex- and depot-specific regulation of lipid metabolism.

Indexed as

Adipose TissueLipidomicsAnimalsAntigens, CDAntigens, NeoplasmDiet, High-FatFemaleLipid MetabolismMaleMiceMice, Inbred C57BLTriglyceridesWeight GainAntigens, CDAntigens, NeoplasmCD248 protein, mouseTriglycerides

Identifiers

PMID37115796
PMCPMC10146461
OpenAlexW4367309493

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.